business

Solinsky EyeCare Partners With ReFocus Eye Health in New Deal

Summarized from GlobalNewswire

Cross Keys Capital advised Solinsky EyeCare on its partnership with ReFocus Eye Health in a move consolidating the eye care sector.

Another day, another eye care roll-up. Solinsky EyeCare just locked in a partnership with ReFocus Eye Health, and Cross Keys Capital ran point as the exclusive financial adviser on the deal. If you're watching the healthcare consolidation space, this one's worth noting.

ReFocus Eye Health has been aggressively building out its platform by partnering with independent eye care practices across the country. Solinsky EyeCare fits squarely into that playbook — a regional provider stepping into a larger network to gain operational scale and capital backing.

Read more EU Antitrust Probe Threatens Saipem-Subsea 7 Merger Deal →

For independent eye care operators still on the sidelines, deals like this signal where the market is heading. Private equity-backed platforms are absorbing quality practices fast, and valuations for well-run independents remain strong. The window won't stay open forever.

Cross Keys Capital specializes in advising founder-owned and private healthcare businesses through transactions exactly like this one — where the right partner and the right terms can define a practice's next decade. Their exclusive advisory role here underscores how specialized M&A counsel is becoming table stakes in healthcare deals.

Continue reading at GlobalNewswire.

Frequently Asked Questions

Q.Who advised Solinsky EyeCare in its partnership with ReFocus Eye Health?

Cross Keys Capital served as the exclusive financial adviser to Solinsky EyeCare in the transaction.

Q.What is ReFocus Eye Health?

ReFocus Eye Health is an eye care platform that partners with independent eye care practices, as evidenced by its deal with Solinsky EyeCare.

Q.What does Cross Keys Capital specialize in?

Cross Keys Capital acts as a financial adviser on partnership and M&A transactions, with this deal representing their exclusive advisory role in the eye care sector.

More in business →